|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||136.70 - 136.70|
|52-week range||136.70 - 136.70|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||186.06|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW YORK, September 16, 2021--IFF (NYSE: IFF) today announced that Glenn Richter, an accomplished financial executive with nearly three decades of experience overseeing finance and corporate strategy for multinational companies, has been appointed Executive Vice President and Chief Financial Officer, effective September 27, 2021. Mr. Richter was most recently Chief Financial Officer of TIAA, a leading global provider of financial services with $1.3 trillion in assets under management. He succeed
NEW YORK, September 01, 2021--IFF (NYSE: IFF) today announced that Chairman & Chief Executive Officer Andreas Fibig and President, Nourish Nicolas Mirzayantz will participate in a virtual fireside chat at the Barclays 2021 Global Consumer Staples Conference on Thursday, September 9, 2021 at 12 pm ET.
NEW YORK, August 23, 2021--IFF (NYSE: IFF) today announced it has entered into an agreement to sell its Microbial Control business unit to LANXESS, a leading specialty chemicals company that develops, manufactures and markets chemical intermediates, additives, specialty chemicals and plastics. The transaction is valued at $1.3 billion and the cash proceeds net of taxes and expenses will be primarily used to reduce outstanding debt.